Skip to main content

Table 5 Basic results. LY and QALY of the options compared

From: Cost-effectiveness analysis of dabigatran and anticoagulation monitoring strategies of vitamin K antagonist

  Life years Quality-adjusted life years
Years since initiation PSM and Dabi PCpc and Hpc and Hvp PSM and Dabi PCpc and Hpc and Hvp
1 0.90 0.88 0.56 0.54
5 3.77 3.55 2.21 2.06
10 6.09 5.51 3.43 3.10
Lifetime 8.45 7.29 4.59 3.99
  1. PSM Patient self-management; PCpc Primary care with portable coagulometer; Hpc Hospital care with portable coagulometer; Hvp Hospital care with venipuncture; Dabi Dabigatran
Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us

\